Elliott Waives BioMarin Board Deal, Moots Del. Suit
By Leslie A. Pappas · April 17, 2024, 2:39 PM EDT
Elliott Investment Management LP has waived an agreement with BioMarin Pharmaceutical Inc. that gave the activist investor three new seats on the biopharmaceutical company's board, mooting a Delaware Chancery Court lawsuit...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login